Safety and efficacy of an oral <scp>CCR</scp>3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo‐controlled clinical trial

Abstract

In conclusion, this study calls into question the role of CCR3 in airway eosinophilia in asthma and suggests that other cellular mechanisms mediated by the CCR3 receptor may contribute to airway hyperresponsiveness.